Pharyngitis, commonly referred to as a sore throat, is an inflammation of the pharynx often caused by infections like Group A Streptococcus (GAS), which is responsible for 14%-37% of cases in higher-income countries, particularly affecting individuals aged 5-19 years. This disease poses a significant clinical burden, with a high unmet need for improved therapies. Current treatments, such as antibiotics, face limitations, including concerns about resistance and recurrence risks. The growing focus on targeted and innovative therapies, including vaccines and novel antimicrobials, is anticipated to drive advancements in the pharyngitis drug pipeline, addressing the gaps in treatment and improving patient outcomes in the coming years.
The Pharyngitis Drug Pipeline Insight Report by Expert Market Research gives comprehensive insights into pharyngitis therapeutics currently undergoing clinical trials. It covers various aspects related to the details of each of these drugs under development for pharyngitis. The pharyngitis report assessment includes the analysis of over 100 pipeline drugs and 50+ companies. The pharyngitis pipeline landscape will include an analysis based on efficacy and safety measure outcomes published for the trials, including their adverse effects on patients suffering from the condition, and alignment with pharyngitis treatment guidelines to ensure optimal care practices.
The assessment part will include a detailed analysis of each drug, drug class, clinical studies, phase type, drug type, route of administration, and ongoing product development activities related to pharyngitis.
Pharyngitis (PKU) is an inflammation of the pharynx, typically caused by viral or bacterial infections. Group A Streptococcus (GAS) is a major bacterial cause, with the disease most commonly affecting children aged 5-19. The condition is often triggered by respiratory infections and can lead to significant discomfort and complications if left untreated.
Pharyngitis treatments mainly include antibiotics for bacterial infections and symptomatic relief for viral cases. Antibiotics like penicillin are used to treat GAS infections, while over-the-counter pain relievers and throat lozenges manage symptoms in viral cases. Despite current treatments, there remains a significant need for more effective therapies to combat recurrent or resistant infections.
Pharyngitis, commonly known as sore throat, is a globally prevalent condition. Acute pharyngitis is a widespread condition leading to approximately 12 million annual ambulatory care visits in the United States, accounting for 1-2% of all ambulatory care visits. Children and adolescents are most affected, with 50% of cases occurring before the age of 18. Adults experience an average of 13.5–14.4 episodes per 100 patient-years, while children face up to 82.5 episodes. Moderate-to-severe pain impacts 70% of patients.
This section of the report covers the analysis of pharyngitis drug candidates based on several segmentations, including:
By Phase
By Drug Class
By Route of Administration
The report covers phase I, phase II, phase III, phase IV, and early-phase drugs. The coverage includes an in-depth analysis of each drug across these phases. According to EMR analysis, phase II covers a major share of the total pharyngitis clinical trials.
The drug molecule categories covered under the pharyngitis pipeline analysis include small molecules, biologics, peptides, gene therapy, immunomodulators, and combination therapies. The report provides a comparative analysis of the drug classes for each drug in various phases of clinical trials for pharyngitis.
The EMR pharyngitis drug report insights include the profile of key companies involved in clinical trials and their drugs under development. Below is the list of a few players involved in pharyngitis clinical trials:
This section covers the detailed analysis of each drug under multiple phases, including phase I, phase II, phase III, phase IV, and emerging drugs for pharyngitis. It includes product description, trial ID, study type, drug class, mode of administration, and recruitment status of pharyngitis drug candidates.
The Phase 4 study is evaluating the effectiveness of phenoxymethylpenicillin versus no antibiotic treatment for Group A Streptococcus-negative sore throat in patients aged 15 and older. The randomized trial, with an estimated enrollment of 260 participants, aims to assess symptom duration and intensity. Completion is anticipated by June 2026.
The Chinese University of Hong Kong is sponsoring a Phase 2 randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of Qingyan Lihou Decoction for treating chronic pharyngolaryngitis, a persistent form of pharyngitis. With 74 participants, the study aims to assess symptom relief over an 8-week treatment period, followed by an 8-week post-treatment evaluation.
This study aims to evaluate the effectiveness of Benzydamine Hydrochloride spray (Difflam) in reducing postoperative sore throat (POST) after the use of a laryngeal mask airway use. This early phase 1 study, involving 106 participants, is expected to be completed by December 2026. The objective is to assess POST incidence, pain severity, and spray safety in perioperative care.
*Please note that this is only a partial list; the complete list of drugs will be available in the full report.*
The Pharyngitis Drug Pipeline Insight Report provides a strategic overview of the latest and future landscape of treatments for pharyngitis. It provides necessary information for making informed investment decisions along with research, development, and strategic planning efforts. The stakeholders will benefit from the essential insights into pharyngitis collaborations, regulatory environments, and potential growth opportunities.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Scope of the Report |
Details |
|
Drug Pipeline by Clinical Trial Phase |
|
|
Route of Administration |
|
|
Drug Classes |
|
|
Leading Sponsors Covered |
|
|
Geographies Covered |
|
Mini Report
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share